AMICOGEN, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,600 KRW | -0.78% |
|
+3.97% | +0.53% |
| Sales 2022 | 144B 105M | Sales 2023 | 160B 116M | Capitalization | 412B 300M |
|---|---|---|---|---|---|
| Net income 2022 | -47.22B -34.33M | Net income 2023 | -23.29B -16.93M | EV / Sales 2022 | 3.4 x |
| Net Debt 2022 | 112B 81.23M | Net Debt 2023 | 111B 80.73M | EV / Sales 2023 | 3.27 x |
| P/E ratio 2022 |
-8.12
x | P/E ratio 2023 |
-13
x | Employees | 216 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.62% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.78% | ||
| 1 week | +3.97% | ||
| Current month | -13.44% | ||
| 1 month | -12.94% | ||
| 3 months | +26.04% | ||
| 6 months | +20.35% | ||
| Current year | +0.53% |
1 week
7 190.00
7 770.00
1 month
6 790.009 200.00
Current year
5 420.009 400.00
1 year
5 420.0010 775.00
3 years
5 420.0023 500.00
5 years
5 200.0024 825.00
10 years
5 200.0031 575.00
| Managers | Title | Age | Since |
|---|---|---|---|
Cheol Park
CEO | Chief Executive Officer | 51 | 23-03-12 |
Yong-Chul Shin
FOU | Founder | 63 | 99-12-31 |
Sang-Hee Lee
DFI | Director of Finance/CFO | 44 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong-Gyun Chung
BRD | Director/Board Member | 63 | - |
Yong-Chul Shin
FOU | Founder | 63 | 99-12-31 |
Tae-Oh Chung
BRD | Director/Board Member | 43 | 18-03-25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 7,600 | -0.78% | 228,552 |
| 24-04-24 | 7,660 | +1.59% | 393,596 |
| 24-04-23 | 7,540 | +0.80% | 334,972 |
| 24-04-22 | 7,480 | +3.46% | 465,904 |
| 24-04-19 | 7,230 | -1.09% | 682,602 |
End-of-day quote Korea S.E., April 24, 2024
More quotes
Amicogen, Inc. is a Korea-based company engaged in the development, production and distribution of enzymes, bio new materials and healthcare food. The Companyâs products consist of special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins. The Company distributes its products within domestic market and to overseas markets, including China, Japan, the United Sates, Germany and Thailand.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +0.53% | 303M | |
| -2.26% | 103B | |
| +1.41% | 95.71B | |
| +0.70% | 22.02B | |
| -17.84% | 20.9B | |
| -9.26% | 17.85B | |
| -42.83% | 16.21B | |
| -17.63% | 15.52B | |
| +4.55% | 13.86B | |
| +32.11% | 12.04B |
- Stock Market
- Equities
- A092040 Stock
